Gold M&A: Pantoro and Tulla Resources join forces to create a A$400m company
Nick Sundich, February 13, 2023
The gold M&A market for 2023 is officially underway with Pantoro (ASX:PNR) and Tulla Resources (ASX:TUL) agreeing to merge. But are these companies actually better off together?
No time to do stock research, but you still want to invest?
Stocks Down Under Concierge gives you timely BUY and SELL alerts on ASX-listed stocks!
With price targets, buy ranges, stop loss levels and Sell alerts too.
GET A 3-MONTH FREE TRIAL TO CONCIERGE TODAY
Pantoro and Tulla are joining forces
Both companies own 50% each of the 4.8Mo Norseman gold project in WA.
Eerily similar to the situation of Strike Energy (ASX:STX) and Warrego Energy (ASX:WGO), a deal had been been tipped for a long time due to the inefficiency of having two companies on the same project.
Today the worst kept secret was confirmed and investors were asked to chip in $75m of fresh equity. This will fund construction, transaction costs and provide general working capital.
Pantoro will own the majority of the new company – with a 51.5% stake – and the hot seat with CEO Paul Cmrlec (yes, that’s his name) heading the combined entity. The combined company is expected to have a ~$400m market capitalisation.
Is this a sign of good things to come for gold M&A?
This gold M&A deal comes a week after a US$17bn proposal by Newmont, the world’s biggest miner, to buy Newcrest Mining (ASX:NCM). This deal has not been accepted yet. Nevertheless, these deals show that it could be a better year for gold M&A in 2023. Last year, only US$2.5bn of deals were completed, down 86% from 2021. But with US$120bn in gold M&A deals completed over the last decade, investors can be optimistic that the market has capacity to bounce back with a vengeance.
Stocks Down Under Concierge gives you timely BUY and SELL alerts on ASX-listed stocks!
With price targets, buy ranges, stop loss levels and Sell alerts too.
GET A 3-MONTH FREE TRIAL TO CONCIERGE TODAY
No credit card needed and the trial expires automatically.
Blog Categories
Recent Posts
Rule of 72: Here’s how investors can use it to their advantage
Here’s why The Rule of 72 might be useful to consider when investing in Stocks Investing in stocks can be…
Novo Nordisk (CPH: NOVO-B): It’s not all smooth sailing for the US$400bn company behind obesity drug Ozempic
Not many 100-year old healthcare stocks see a sudden 30% jump in sales in one year, but Novo Nordisk (CPH:…
Bapcor (ASX:BAP): Its been a horror week with a 3rd profit downgrade in less than a year
This week investors in Bapcor (ASX:BAP) saw a 3rd profit downgrade in less than a year and its CEO-elect walk…